Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway-Reference-Cited by-同舟云学术

Interleukin-22 (IL-22) Regulates Apoptosis of Paclitaxel-Resistant Non-Small Cell Lung Cancer Cells Through C-Jun N-Terminal Kinase Signaling Pathway

Published:2018-05-03 Issue: Volume:24 Page:2750-2757
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Li Chenchen¹,Zhao Xia²,Yang Yang¹,Liu Siwen¹,Liu Yun¹,Li Xiaoyou¹

Affiliation:

1. Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China (mainland)

2. Department of Medical Oncology, First People’s Hospital of Yancheng, Fourth Affiliated Hospital of Nantong University, Yancheng, Jiangsu, China (mainland)

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPRC5A promotes paclitaxel resistance and glucose content in NSCLC;Anti-Cancer Drugs;2024-04-08

2. Th22 Cells/IL-22 Serves as a Protumor Regulator to Drive Poor Prognosis through the JAK-STAT3/MAPK/AKT Signaling Pathway in Non-Small-Cell Lung Cancer;Journal of Immunology Research;2022-05-28

3. Mechanisms of resistance to chemotherapy in non-small cell lung cancer;Archives of Pharmacal Research;2021-02

4. Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance;Current Medicinal Chemistry;2020-11-24

5. IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways;Frontiers in Oncology;2019-11-05